1,058
Views
1
CrossRef citations to date
0
Altmetric
Research Article

An overview of the use of psychoactive substances among students at the University of Lille during the COVID-19 health crisis: Results of the PETRA study

ORCID Icon, , , , , , , , & show all
Pages 101-111 | Received 21 Dec 2022, Accepted 03 Oct 2023, Published online: 14 Oct 2023

References

  • Agence Nationale de Sécurité des Médicaments et des Produits de Santé. 2007. Méthylphénidate : données d’utilisation et de sécurité d’emploi en France – ANSM. [accessed 2022 Oct 10] https://ansm.sante.fr/actualites/methylphenidate-donnees-dutilisation-et-de-securite-demploi-en-france.
  • Agence Nationale de Sécurité des Médicaments et des Produits de Santé. 2022a. Résumé des caractéristiques du produit - RITALINE L.P. 10 mg, gélule à libération prolongée - Base de données publique des medicaments. [accessed 2022 Jul 25]. https://base-donnees-publique.medicaments.gouv.fr/affichageDoc.php?specid=61810983&typedoc=R.
  • Agence Nationale de Sécurité des Médicaments et des Produits de Santé. 2022b. Résumé des caractéristiques du produit – MODIODAL 100 mg, comprimé – Base de données publique des medicaments. [accessed 2022 Jul 25]. https://base-donnees-publique.medicaments.gouv.fr/affichageDoc.php?specid=66805883&typedoc=R.
  • Ashrafioun L, Heavey S, Canarapen T, Bishop TM, Pigeon WR. 2019. The relationship between past 12-month suicidality and reasons for prescription opioid misuse. J Affect Disord. 249:45–51. doi: 10.1016/j.jad.2019.02.008.
  • Batisse A, Eiden C, Deheul S, Monzon E, Djezzar S, Peyrière H. 2022. Chemsex practice in France: an update in addictovigilance data. Fundam Clin Pharmacol. 36(2):397–404. doi: 10.1111/fcp.12725.
  • Batisse A, Leger S, Vicaut E, Gerbaud L, Djezzar S. 2021. COgnitive enhancement and consumption of psychoactive substances among youth students (COSYS): a cross-sectional study in France. Public Health. 194:75–78. doi: 10.1016/j.puhe.2021.02.036.
  • Biancuzzi H, Dal Mas F, Brescia V, Campostrini S, Cascella M, Cuomo A, Cobianchi L, Dorken-Gallastegi A, Gebran A, Kaafarani HM, et al. 2022. Opioid misuse: a review of the main issues, challenges, and strategies. Int J Environ Res Public Health. 19(18):11754. doi: 10.3390/ijerph191811754.
  • Blaise M, Rossé E. 2011. Monsieur Drogue. Claude Olievenstein, trente ans d’interventions médiatiques. Psychotropes. Vol. 17(1):57–82. doi: 10.3917/psyt.171.0057.
  • Bonnay M, Soeiro T, Megard R, Micallef J, Rolland B, Chappuy M. 2021. Usages et bon usage des benzodiazépines anxiolytiques et hypnotiques. Annales Médico-Psychologiques, Revue Psychiatrique. 179(8):748–756. doi: 10.1016/j.amp.2021.08.009.
  • Carton L, Cabé N, Ménard O, Deheul S, Caous A-S, Devos D, Cottencin O, Bordet R. 2018. Pharmaceutical cognitive doping in students: a chimeric way to get-a-head? Therapie. 73(4):331–339. doi: 10.1016/j.therap.2018.02.005.
  • Douzenis A, Michopoulos I, Lykouras L. 2006. Sulbutiamine, an “innocent” over the counter drug, interferes with therapeutic outcome of bipolar disorder. World J Biol Psychiatry. 7(3):183–185. doi: 10.1080/15622970500492616.
  • Fidalgo M, Prud’homme T, Allio A, Bronnec M, Bulteau S, Jolliet P, Victorri-Vigneau C. 2019. Nitrous oxide: what do we know about its use disorder potential? Results of the French Monitoring Centre for addiction network survey and literature review. Subst Abus. 40(1):33–42. doi: 10.1080/08897077.2019.1573210.
  • Fond G, Gavaret M, Vidal C, Brunel L, Riveline J-P, Micoulaud-Franchi J-A, Domenech P. 2016. (Mis)use of prescribed stimulants in the medical student community: motives and behaviors: a population-based cross-sectional study. Medicine. 95(16):e3366. doi: 10.1097/MD.0000000000003366.
  • Fonseca F, Robles-Martínez M, Tirado-Muñoz J, Alías-Ferri M, Mestre-Pintó J-I, Coratu AM, Torrens M. 2021. A gender perspective of addictive disorders. Curr Addict Rep. 8(1):89–99. doi: 10.1007/s40429-021-00357-9.
  • Galea S, Tracy M. 2007. Participation rates in epidemiologic studies. Ann Epidemiol. 17(9):643–653. doi: 10.1016/j.annepidem.2007.03.013.
  • Gukasyan N, Strain EC. 2020. Relationship between cannabis use frequency and major depressive disorder in adolescents: findings from the National Survey on drug use and health 2012–2017. Drug Alcohol Depend. 208:107867. doi: 10.1016/j.drugalcdep.2020.107867.
  • Hartung CM, Canu WH, Cleveland CS, Lefler EK, Mignogna MJ, Fedele DA, Correia CJ, Leffingwell TR, Clapp JD. 2013. Stimulant medication use in college students: comparison of appropriate users, misusers, and nonusers. Psychol Addict Behav. 27(3):832–840. doi: 10.1037/a0033822.
  • Hildt E, Lieb K, Bagusat C, Franke AG. 2015. Reflections on addiction in students using stimulants for neuroenhancement: a preliminary interview study. Biomed Res Int. 2015:621075–621077. doi: 10.1155/2015/621075.
  • Jouanjus E, Raymond V, Lapeyre-Mestre M, Wolff V. 2017. What is the current knowledge about the cardiovascular risk for users of cannabis-based products? A systematic review. Curr Atheroscler Rep. 19(6):26. doi: 10.1007/s11883-017-0663-0.
  • Kasperski SJ, Vincent KB, Caldeira KM, Garnier-Dykstra LM, O'Grady KE, Arria AM. 2011. College students’ use of cocaine: results from a longitudinal study. Addict Behav. 36(4):408–411. doi: 10.1016/j.addbeh.2010.12.002.
  • Kerckhove N, Delage N, Bertin C, Kuhn E, Cantagrel N, Vigneau C, Delorme J, Lambert C, Pereira B, Chenaf C, et al. 2022. Cross-sectional study of the prevalence of prescription opioids misuse in French patients with chronic non-cancer pain: an update with the French version of the POMI scale. Front Pharmacol. 13:947006. doi: 10.3389/fphar.2022.947006.
  • Lapeyre-Mestre M, Boucher A, Daveluy A, Gibaja V, Jouanjus E, Mallaret M, Peyrière H, Micallef J, French Addictovigilance Network. 2020. Addictovigilance contribution during COVID-19 epidemic and lockdown in France. Therapie. 75(4):343–354. doi: 10.1016/j.therap.2020.06.006.
  • Lapeyre-Mestre M, Boyer A, Ponté C, Daveluy A, Godeau E. 2021. Substance use among young people: from medicine to illicit substances. Therapie. 76(1):31–35. doi: 10.1016/j.therap.2020.07.003.
  • Largeau B, Karam A, Potey C, Caous A-S, Tard C, Carton L, Kuchcinski G, Gautier S, Deheul S, Bordet R, et al. 2022. Myeloneuropathy induced by recreational nitrous oxide use with variable exposure levels. Eur J Neurol. 29(8):2173–2180. doi: 10.1111/ene.15370.
  • Luo Y, Chua CR, Xiong Z, Ho RC, Ho CSH. 2020. A systematic review of the impact of viral respiratory epidemics on mental health: an implication on the coronavirus disease 2019 pandemic. Front Psychiatry. 11:565098. doi: 10.3389/fpsyt.2020.565098.
  • Malandain L, Mosser S, Mouchabac S, Blanc J-V, Alexandre C, Thibaut F. 2021. Chemical sex (chemsex) in a population of French university students. Dialogues Clin Neurosci. 23(1):39–43. doi: 10.1080/19585969.2022.2042163.
  • Micallef J, Mallaret M, Lapeyre-Mestre M, Daveluy A, Victorri-Vigneau C, Peyrière H, Debruyne D, Deheul S, Bordet R, Chevallier C, et al. 2021. Warning on increased serious health complications related to non-medical use of nitrous oxide. Therapie. 76(5):478–479. doi: 10.1016/j.therap.2020.01.002.
  • Nutt D, King LA, Saulsbury W, Blakemore C. 2007. Development of a rational scale to assess the harm of drugs of potential misuse. Lancet. 369(9566):1047–1053. doi: 10.1016/S0140-6736(07)60464-4.
  • Oulkadi S, Peters B, Vliegen A-S. 2022. Thromboembolic complications of recreational nitrous oxide (ab)use: a systematic review. J Thromb Thrombolysis. 54(4):686–695. doi: 10.1007/s11239-022-02673-x.
  • Pauly V, Frauger E, Lepelley M, Mallaret M, Boucherie Q, Micallef J. 2019. Overuse or underuse of methylphenidate in adults in France: commentary on Pauly et al. 2018. Br J Clin Pharmacol. 85(1):275–276. doi: 10.1111/bcp.13758.
  • Perino J, Tournier M, Mathieu C, Letinier L, Peyré A, Perret G, Pereira E, Fourrier-Réglat A, Pollet C, Fatseas M, et al. 2022. Psychoactive substance use among students: a cross-sectional analysis. Fundam Clin Pharmacol. 36(5):908–914. doi: 10.1111/fcp.12771.
  • Rabiner DL, Anastopoulos AD, Costello EJ, Hoyle RH, McCabe SE, Swartzwelder HS. 2009. Motives and perceived consequences of nonmedical ADHD medication use by college students: are students treating themselves for attention problems? J Atten Disord. 13(3):259–270. doi: 10.1177/1087054708320399.
  • R Core Team (2013) R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna.
  • Ren Z, Xin Y, Ge J, Zhao Z, Liu D, Ho RCM, Ho CSH. 2021. Psychological impact of COVID-19 on college students after school reopening: a cross-sectional study based on machine learning. Front Psychol. 12:641806. doi: 10.3389/fpsyg.2021.641806.
  • Schelle KJ, Olthof BMJ, Reintjes W, Bundt C, Gusman-Vermeer J, van Mil ACCM. 2015. A survey of substance use for cognitive enhancement by university students in the Netherlands. Front Syst Neurosci. 9:10. doi: 10.3389/fnsys.2015.00010.
  • Sharif S, Guirguis A, Fergus S, Schifano F. 2021. The use and impact of cognitive enhancers among university students: a systematic review. Brain Sci. 11(3):355. doi: 10.3390/brainsci11030355.
  • Substance Abuse and Mental Health Services Administration, Behavioral Health Among College Students Information & Resource Kit. HHS Publication No. (SMA) 19-5052. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2019.
  • Tavolacci MP, Ladner J, Grigioni S, Richard L, Villet H, Dechelotte P. 2013. Prevalence and association of perceived stress, substance use and behavioral addictions: a cross-sectional study among university students in France, 2009–2011. BMC Public Health. 13(1):724. doi: 10.1186/1471-2458-13-724.
  • Team Rs. 2020. RStudio: integrated development for R. Boston, MA: RStudio, PBC.
  • Université de Lille. 2021. Repéres statistiques. Etudiants et formations. 2021. https://odif.univ-lille.fr/reperes-statistiques/
  • Wang C, Pan R, Wan X, Tan Y, Xu L, Ho CS, Ho RC. 2020. Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China. Int J Environ Res Public Health. 17(5):1729. doi: 10.3390/ijerph17051729.
  • Wathelet M, Duhem S, Vaiva G, Baubet T, Habran E, Veerapa E, Debien C, Molenda S, Horn M, Grandgenèvre P, et al. 2020. Factors associated with mental health disorders among university students in France confined during the COVID-19 pandemic. JAMA Netw Open. 3(10):e2025591. doi: 10.1001/jamanetworkopen.2020.25591.
  • Weibel S, Menard O, Ionita A, Boumendjel M, Cabelguen C, Kraemer C, Micoulaud-Franchi J-A, Bioulac S, Perroud N, Sauvaget A, et al. 2020. Practical considerations for the evaluation and management of attention deficit hyperactivity disorder (ADHD) in adults. Encephale. 46(1):30–40. doi: 10.1016/j.encep.2019.06.005.
  • Xiong J, Lipsitz O, Nasri F, Lui LMW, Gill H, Phan L, Chen-Li D, Iacobucci M, Ho R, Majeed A, et al. 2020. Impact of COVID-19 pandemic on mental health in the general population: a systematic review. J Affect Disord. 277:55–64. doi: 10.1016/j.jad.2020.08.001.